Aurora: Investor Presentation
Significant Opportunity Across Medical,
Consumer and Wellness Markets
Expected global
disruption in
the beverage,
pharmaceutical,
CPG and tobacco
industries
Source: BMO Research and Deloitte
1. Estimated for Canadian Medical TAM assumes LPs obtain retail prices for cannabis.
2. Estimate for total potential market opportunity for Canadian Adult-Use.
~$3
billion
Canadian
Medical (1)
-$9
billion
Canadian
Consumer(2)
~$70+
billion
Global
Medical (3)
~$115+
billion
Global
Consumer (4)
Total global cannabis opportunity is ~$200 billion
3. Estimate consists of medical markets for the U.S., EU and LATAM markets only and assumes EU and LATAM TAM based on
wholesale pricing while US TAM assumes retail pricing.
4. Estimate consists of adult-use markets for the U.S. and EU markets only and assumes that LPs obtain retail pricing for cannabis.
AURORA 8View entire presentation